COVID ‘Compromise’ on International IP Underscores Need for New Approach
Bill of Health
APRIL 6, 2022
It only narrowly modifies compulsory licenses of patents covering COVID vaccines. IP on COVID vaccines should be a global public good. For COVID treatments and diagnostics to be broadly available at affordable prices, their IP must be considered a global public good by all. We need a new approach.
Let's personalize your content